Notification of Major Interest in Mediclinic International plc shares Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 (“Mediclinic”, the “Company” or the “Group”) Notification of Major Interest in Mediclinic International plc shares 1a. Identity of the issuer or the underlying issuer Mediclinic International plc. of existing shares to which voting rights are at- tached: 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for the notification (please mark the appropriate box or boxes with an “X”) An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments An event changing the breakdown of voting rights Other (please specify): 3. Details of person subject to the notification obligation Coronation Asset Management (Pty) Ltd acting as Name discretionary investment manager on behalf of managed portfolios. City and country of registered office (if applicable) Cape Town, South Africa 4. Full name of shareholder(s) (if different from 3.) Name N/A City and country of registered office (if applicable) 5. Date on which the threshold was crossed or 26/10/2017 reached: 6. Date on which issuer notified (DD/MM/YYYY): 26/10/2017 7. Total positions of person(s) subject to the notification obligation % of voting rights % of voting rights through financial in- Total number of Total of both in % attached to shares struments voting rights of (8.A + 8.B) (total of 8. A) (total of 8.B 1 + 8.B issuer 2) Resulting situation on the date on which threshold 5.01% 5.01% 737 243 810 was crossed or reached Position of previ- ous notification (if 4.90% 4.90% applicable) 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached A: Voting rights attached to shares Class/type of Number of voting rights % of voting rights shares Direct Indirect Direct Indirect ISIN code (if possi- ble) (Art 9 of Directive (Art 10 of Di- (Art 9 of Directive (Art 10 of Di- 2004/109/EC) rective 2004/109/EC) rective (DTR5.1) 2004/109/EC) (DTR5.1) 2004/109/EC) (DTR5.2.1) (DTR5.2.1) GB00B8HX8Z88 36 951 344 5.01% SUBTOTAL 8. A 36 951 344 5.01% B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) Number of voting Expira- rights that may be ac- Type of financial Exercise/ % of voting tion quired if the instru- instrument Conversion Period ment is rights date exercised/converted. SUBTOTAL 8. B 1 B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) Exercise/ Physical or Type of finan- Expiration Number of % of voting Conversion cash cial instrument date voting rights rights Period settlement SUBTOTAL 8.B.2 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”) Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (under- lying) issuer Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal X entity (please add additional rows as necessary) % of voting rights % of voting rights through financial Total of both if it if it equals or is instruments if it equals or is higher Name higher than the equals or is higher than the notifiable notifiable thresh- than the notifiable threshold old threshold Coronation Fund Managers Ltd Coronation Investment Manage- ment SA (Pty) Ltd Coronation Asset Management 5.01% 5.01% (Pty) Ltd 10. In case of proxy voting, please identify: Name of the proxy holder The number and % of voting rights held The date until which the voting rights will be held 11. Additional information Place of completion Cape Town, South Africa Date of completion 26/10/2017 27 October 2017 Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia. Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom Website: www.mediclinic.com Corporate broker: Morgan Stanley & Co International plc JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Ltd For further information please contact: Mediclinic International plc James Arnold, Head of Investor Relations ir@mediclinic.com +44 (0)20 3786 8181 Capita Company Secretarial Services Limited Victoria Dalby +44 (0)207 954 9600 Date: 27/10/2017 11:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.